TI
ACHN

Telemetry Investments’s Achillion Pharmaceuticals ACHN Stock Holding History

Telemetry Investments’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-48,305
Closed -$137K – 190
2018
Q2 		$137K Sell
48,305
-51,695
-52% -$176K 0.16% 118
2018
Q1 		$371K Sell
100,000
-35,000
-26% -$115K 0.4% 87
2017
Q4 		$389K Buy
+135,000
New +$490K 0.49% 81
2015
Q3 		– Sell
-65,000
Closed -$576K – 192
2015
Q2 		$576K Buy
65,000
+20,000
+44% +$189K 0.37% 72
2015
Q1 		$444K Buy
45,000
+5,000
+13% +$62.4K 0.33% 75
2014
Q4 		$490K Buy
+40,000
New +$488K 0.35% 77

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return